205 related articles for article (PubMed ID: 10952566)
1. Sodium lauryl sulfate increases the efficacy of a topical formulation of foscarnet against herpes simplex virus type 1 cutaneous lesions in mice.
Piret J; Désormeaux A; Cormier H; Lamontagne J; Gourde P; Juhász J; Bergeron MG
Antimicrob Agents Chemother; 2000 Sep; 44(9):2263-70. PubMed ID: 10952566
[TBL] [Abstract][Full Text] [Related]
2. Efficacies of gel formulations containing foscarnet, alone or combined with sodium lauryl sulfate, against establishment and reactivation of latent herpes simplex virus type 1.
Piret J; Lamontagne J; Désormeaux A; Bergeron MG
Antimicrob Agents Chemother; 2001 Apr; 45(4):1030-6. PubMed ID: 11257012
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo evaluations of sodium lauryl sulfate and dextran sulfate as microbicides against herpes simplex and human immunodeficiency viruses.
Piret J; Lamontagne J; Bestman-Smith J; Roy S; Gourde P; Désormeaux A; Omar RF; Juhász J; Bergeron MG
J Clin Microbiol; 2000 Jan; 38(1):110-9. PubMed ID: 10618073
[TBL] [Abstract][Full Text] [Related]
4. Efficacies of topical formulations of foscarnet and acyclovir and of 5-percent acyclovir ointment (Zovirax) in a murine model of cutaneous herpes simplex virus type 1 infection.
Piret J; Désormeaux A; Gourde P; Juhász J; Bergeron MG
Antimicrob Agents Chemother; 2000 Jan; 44(1):30-8. PubMed ID: 10602719
[TBL] [Abstract][Full Text] [Related]
5. Comparative study of mechanisms of herpes simplex virus inactivation by sodium lauryl sulfate and n-lauroylsarcosine.
Piret J; Roy S; Gagnon M; Landry S; Désormeaux A; Omar RF; Bergeron MG
Antimicrob Agents Chemother; 2002 Sep; 46(9):2933-42. PubMed ID: 12183250
[TBL] [Abstract][Full Text] [Related]
6. Thermoreversible gel formulations containing sodium lauryl sulfate or n-Lauroylsarcosine as potential topical microbicides against sexually transmitted diseases.
Roy S; Gourde P; Piret J; Désormeaux A; Lamontagne J; Haineault C; Omar RF; Bergeron MG
Antimicrob Agents Chemother; 2001 Jun; 45(6):1671-81. PubMed ID: 11353610
[TBL] [Abstract][Full Text] [Related]
7. Successful treatment of progressive mucocutaneous infection due to acyclovir- and foscarnet-resistant herpes simplex virus with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC).
Snoeck R; Andrei G; Gérard M; Silverman A; Hedderman A; Balzarini J; Sadzot-Delvaux C; Tricot G; Clumeck N; De Clercq E
Clin Infect Dis; 1994 Apr; 18(4):570-8. PubMed ID: 8038312
[TBL] [Abstract][Full Text] [Related]
8. Treatment of acyclovir-resistant herpetic ulceration with topical foscarnet and antiviral sensitivity analysis.
Pechère M; Wunderli W; Trellu-Toutous L; Harms M; Saura JH; Krischer J
Dermatology; 1998; 197(3):278-80. PubMed ID: 9812037
[TBL] [Abstract][Full Text] [Related]
9. Correlation of in vivo topical efficacies with in vitro predictions using acyclovir formulations in the treatment of cutaneous HSV-1 infections in hairless mice: an evaluation of the predictive value of the C* concept.
Patel PJ; Ghanem AH; Higuchi WI; Srinivasan V; Kern ER
Antiviral Res; 1996 Mar; 29(2-3):279-86. PubMed ID: 8739606
[TBL] [Abstract][Full Text] [Related]
10. Effect of Azone upon the in vivo antiviral efficacy of cidofovir or acyclovir topical formulations in treatment/prevention of cutaneous HSV-1 infections and its correlation with skin target site free drug concentration in hairless mice.
Afouna MI; Fincher TK; Zaghloul AA; Reddy IK
Int J Pharm; 2003 Mar; 253(1-2):159-68. PubMed ID: 12593946
[TBL] [Abstract][Full Text] [Related]
11. Long-term follow-up of HIV-infected patients once diagnosed with acyclovir-resistant herpes simplex virus infection.
Seang S; Boutolleau D; Burrel S; Regnier S; Epelboin L; Voujon D; Valantin MA; Katlama C; Agut H; Caumes E
Int J STD AIDS; 2014 Aug; 25(9):676-82. PubMed ID: 24535691
[TBL] [Abstract][Full Text] [Related]
12. Influence of the treatment protocol upon the in vivo efficacy of cidofovir (HPMPC) and of acyclovir (ACV) formulations in topical treatment of cutaneous HSV-1 infection in hairless mice.
Afouna MI; Mehta SC; Ghanem AH; Higuchi WI; Kern ER; DeClercq E; El-Shattawy HH
J Pharm Sci; 1999 May; 88(5):530-4. PubMed ID: 10229644
[TBL] [Abstract][Full Text] [Related]
13. Microemulsion-based oxyresveratrol for topical treatment of herpes simplex virus (HSV) infection: physicochemical properties and efficacy in cutaneous HSV-1 infection in mice.
Sasivimolphan P; Lipipun V; Ritthidej G; Chitphet K; Yoshida Y; Daikoku T; Sritularak B; Likhitwitayawuid K; Pramyothin P; Hattori M; Shiraki K
AAPS PharmSciTech; 2012 Dec; 13(4):1266-75. PubMed ID: 22996670
[TBL] [Abstract][Full Text] [Related]
14. Development of novel microemulsion-based topical formulations of acyclovir for the treatment of cutaneous herpetic infections.
Shishu ; Rajan S; Kamalpreet
AAPS PharmSciTech; 2009; 10(2):559-65. PubMed ID: 19504745
[TBL] [Abstract][Full Text] [Related]
15. Quantification of sodium lauryl sulfate penetration into the skin and underlying tissue after topical application--pharmacological and toxicological implications.
Patil S; Singh P; Sarasour K; Maibach H
J Pharm Sci; 1995 Oct; 84(10):1240-4. PubMed ID: 8801341
[TBL] [Abstract][Full Text] [Related]
16. Successful foscarnet therapy for acyclovir-resistant mucocutaneous infection with herpes simplex virus in a recipient of allogeneic BMT.
Verdonck LF; Cornelissen JJ; Smit J; Lepoutre J; de Gast GC; Dekker AW; Rozenberg-Arska M
Bone Marrow Transplant; 1993 Feb; 11(2):177-9. PubMed ID: 8382096
[TBL] [Abstract][Full Text] [Related]
17. Limited efficacy of inhibitors of herpes simplex virus DNA synthesis in murine models of recrudescent disease.
Kristofferson A; Ericson AC; Sohl-Akerlund A; Datema R
J Gen Virol; 1988 Jun; 69 ( Pt 6)():1157-66. PubMed ID: 2838569
[TBL] [Abstract][Full Text] [Related]
18. Herpes simplex virus-1 entrapped in Candida albicans biofilm displays decreased sensitivity to antivirals and UVA1 laser treatment.
Ascione C; Sala A; Mazaheri-Tehrani E; Paulone S; Palmieri B; Blasi E; Cermelli C
Ann Clin Microbiol Antimicrob; 2017 Nov; 16(1):72. PubMed ID: 29137671
[TBL] [Abstract][Full Text] [Related]
19. Sodium lauryl sulfate, a microbicide effective against enveloped and nonenveloped viruses.
Piret J; Désormeaux A; Bergeron MG
Curr Drug Targets; 2002 Feb; 3(1):17-30. PubMed ID: 11899262
[TBL] [Abstract][Full Text] [Related]
20. Bone marrow transplantation in a child with Wiskott-Aldrich syndrome latently infected with acyclovir-resistant (ACV(r)) herpes simplex virus type 1: emergence of foscarnet-resistant virus originating from the ACV(r) virus.
Saijo M; Yasuda Y; Yabe H; Kato S; Suzutani T; De Clercq E; Niikura M; Maeda A; Kurane I; Morikawa S
J Med Virol; 2002 Sep; 68(1):99-104. PubMed ID: 12210436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
